Monday, January 18, 2010

Who will acquire Ratiopharm - Teva or Pfizer?

The race for German generic-drug maker Ratiopharm has practically narrowed to Israel's Teva and U.S. drug major Pfizer, German business daily Handelsblatt reported on Monday.

EQT also remains a bidder but the Swedish buy-out firm's chances are seen as slim because it stands to gain fewer synergies from the deal and has less financial fire power than its rivals from the healthcare industry, the newspaper cited financial sources as saying.

More at Reuters

1 comment:

PharmaHeretic said...

My idea is either a new drug for treating chronic pain or addicts will thank me.. only time will tell.

Designing Opioid-TRIs for Chronic Pain.

http://pharmaheretic.wordpress.com/2010/01/18/designing-opioid-tris-for-pain/